Back to Journals » Advances in Genomics and Genetics » Volume 4

Insights into the genetic basis of systemic sclerosis: immunity in human disease and in mouse models

Authors Wu M, Mayes MD

Received 16 May 2014

Accepted for publication 5 July 2014

Published 26 September 2014 Volume 2014:4 Pages 143—151

DOI https://doi.org/10.2147/AGG.S46813

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Minghua Wu, Maureen D Mayes

Division of Rheumatology and Clinical Immunogenetics, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, TX, USA

Abstract: Systemic sclerosis (SSc; scleroderma) is a chronic, multisystem autoimmune disease characterized by vasculopathy, fibrosis, and autoantibodies. In the past decade, great efforts have been made to investigate genetic susceptibility for SSc. To date, over 20 gene loci have been identified as risk factors for SSc in large genome-wide association studies and confirmed by independent replication studies. However, the biological relevance of these genetic associations is still largely unknown. Exploring the mechanism behind these risk loci is essential to better understand disease pathogenesis and to identify novel therapeutic targets. Mouse model studies including knockout, knockin and knockdown of these genes can advance our understanding of pathogenic cellular and molecular mechanisms in human disease. Although such mouse model systems do not exactly correspond to human disease, they can provide insight into pathological mechanisms that influence disease pathways. In this review, we discuss recent findings regarding the genetic basis of SSc in the setting of genetic manipulation of these pathways in murine models.

Keywords: GWAS, Immunochip study, type I interferon pathway, genetic mutation animal models

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010